The Board of Directors of Beacon Pharmaceuticals Ltd. has recommended 16% cash dividend for the year ended on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
137.7 BDT | -2.96% | -9.11% | -43.80% |
1st Jan change | Capi. | |
---|---|---|
-43.80% | 279M | |
+18.07% | 41.97B | |
+22.39% | 22.34B | |
+18.48% | 15.25B | |
+17.82% | 14B | |
+48.11% | 12.06B | |
-10.45% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- BEACONPHAR Stock
- News Beacon Pharmaceuticals PLC
- Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2022